# Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases

> **NCT00849745** · PHASE1 · TERMINATED · sponsor: **Duke University** · enrollment: 4 (actual)

## Conditions studied

- Systemic Lupus Erythematosus
- Systemic Sclerosis

## Interventions

- **PROCEDURE:** Nonmyeloablative allogeneic stem cell transplant

## Key facts

- **NCT ID:** NCT00849745
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2016-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849745, "Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00849745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*